Unilever’s agreement to acquire US greens supplement company Grüns points to a continued reshaping of the group towards faster-growing, more premium categories where brand positioning and consumer loyalty can support a stronger growth profile over time. Unilever is leaning further into wellbeing, with a particular emphasis on the US market, and using portfolio moves to strengthen its exposure to areas that sit closer to health, daily habit formation and premium consumer spend.
Grüns is still a young business, having been founded in 2023, but it has built momentum quickly in the US greens supplement segment. Its proposition is centred on making daily nutrient support more convenient and more appealing through gummy-based products, rather than relying on more traditional supplement formats.
The deal also fits with Unilever’s broader effort to optimise its brand mix. Management has been increasingly clear that capital allocation should favour categories with better structural growth and stronger premiumisation potential. Beauty and wellbeing remain central to that effort, and Grüns appears to sit neatly within that framework.
For investors in Finsbury Growth & Income Trust, which has a 10.4% portfolio holding in Unilever, the acquisition is therefore notable as a small but telling example of how one of the trust’s largest positions is trying to improve its category mix and sharpen its long-term positioning.
Finsbury Growth & Income Trust Plc (LON:FGT) invests in the shares of predominantly UK-listed companies, with the objective of achieving capital and income growth.
